Search tips
Search criteria 


Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2010; 5(10): 10.1371/annotation/bdcb41f2-a320-4401-a6ab-86e71738597e.
Published online 2010 October 29. doi:  10.1371/annotation/bdcb41f2-a320-4401-a6ab-86e71738597e
PMCID: PMC2976855

Correction: Extracranial Sources of S100B Do Not Affect Serum Levels

In our recent article [1], we did not declare several potential competing interests relevant to this work. We apologize for this omission and would like to disclose the following information:

Dr. Janigro has received royalty payments from Roche Diagnostics and holds a patent on S100B for its use as a serum marker for blood-brain barrier leakage.

The study was partly supported by Roche Diagnostics. The company does not currently develop any products related to the results described in the article.


1. Pham N, Fazio V, Cucullo L, Teng Q, Biberthaler P, Bazarian JJ, Janigro D (2010) Extracranial sources of S100B do not affect serum levels. PLoS One 5(9): e12691. doi:10.1371/journal.pone.0012691


Competing Interests: No competing interests declared.

Articles from PLoS ONE are provided here courtesy of Public Library of Science